Parplus Partners’s Eli Lilly LLY Stock Holding History

Parplus Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,010	Closed	-$658K	–	78
2019 Q4	$658K	Buy	+5,010	New	+$581K	0.13%	34

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parplus Partners's LLY Position: Q1 2020 in Review

Parplus Partners sold out of Eli Lilly (LLY) in Q1 2020, closing a stake of 5,010 shares — an estimated $658K sold.

Parplus Partners first reported a position in LLY in Q4 2019 and held it in 1 quarter. The position peaked at $658K in Q4 2019. 1,684 funds tracked by Wall St. Rank hold LLY as of Q1 2020.

Parplus Partners reported no remaining Eli Lilly position as of Q1 2020 after selling out during the quarter.
Parplus Partners sold 5,010 Eli Lilly shares in Q1 2020, an estimated $658K.
Parplus Partners first reported a position in Eli Lilly in Q4 2019 and held it in 1 quarter.
Parplus Partners's Eli Lilly position peaked at $658K in Q4 2019.
1,684 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2020.

Based on Parplus Partners's 13F filing for Q1 2020, filed 14 May 2020.